Juvenile idiopathic arthritis in infants with Harlequin Ichthyosis: two cases report and literature review.
Acitretin
Case report
Harlequin Ichthyosis
Juvenile idiopathic arthritis
Oral retinoids
Journal
Italian journal of pediatrics
ISSN: 1824-7288
Titre abrégé: Ital J Pediatr
Pays: England
ID NLM: 101510759
Informations de publication
Date de publication:
15 Apr 2020
15 Apr 2020
Historique:
received:
11
03
2020
accepted:
07
04
2020
entrez:
16
4
2020
pubmed:
16
4
2020
medline:
3
3
2021
Statut:
epublish
Résumé
Harlequin Ichthyosis is the most severe variant of congenital autosomal recessive ichthyosis, associated with severe morbidity and potentially lethal in early life. At birth, patients present thick and plaque-like scales all over the body, with consequent cutaneous and extra-cutaneous complications, such as poor thermoregulation, recurrent infections, pain, electrolytes imbalance and joint contractures. Juvenile Idiopathic Arthritis usually manifests before the age of 16 years and persists for more than 6 weeks. The association between these two pathologies has been described in the literature as a very rare event, which creates diagnostic and therapeutic challenge. We describe two patients affected by Harlequin Ichthyosis who early developed Juvenile Idiopathic Arthritis. Both patients were treated with retinoids, ibuprofen and long-acting intra-articular glucocorticoids; due to polyarticular involvement, one child was also treated with weekly oral methotrexate. The association between Harlequin Ichthyosis and Juvenile Idiopathic Arthritis is rare and the pathophysiological mechanism that binds them is still unknown. Nonetheless caregivers should be aware of the possible occurrence of Juvenile Idiopathic Arthritis at very early ages in children affected by Harlequin Ichthyosis.
Sections du résumé
BACKGROUND
BACKGROUND
Harlequin Ichthyosis is the most severe variant of congenital autosomal recessive ichthyosis, associated with severe morbidity and potentially lethal in early life. At birth, patients present thick and plaque-like scales all over the body, with consequent cutaneous and extra-cutaneous complications, such as poor thermoregulation, recurrent infections, pain, electrolytes imbalance and joint contractures. Juvenile Idiopathic Arthritis usually manifests before the age of 16 years and persists for more than 6 weeks. The association between these two pathologies has been described in the literature as a very rare event, which creates diagnostic and therapeutic challenge.
CASE PRESENTATION
METHODS
We describe two patients affected by Harlequin Ichthyosis who early developed Juvenile Idiopathic Arthritis. Both patients were treated with retinoids, ibuprofen and long-acting intra-articular glucocorticoids; due to polyarticular involvement, one child was also treated with weekly oral methotrexate.
CONCLUSIONS
CONCLUSIONS
The association between Harlequin Ichthyosis and Juvenile Idiopathic Arthritis is rare and the pathophysiological mechanism that binds them is still unknown. Nonetheless caregivers should be aware of the possible occurrence of Juvenile Idiopathic Arthritis at very early ages in children affected by Harlequin Ichthyosis.
Identifiants
pubmed: 32293521
doi: 10.1186/s13052-020-0817-5
pii: 10.1186/s13052-020-0817-5
pmc: PMC7158043
doi:
Types de publication
Case Reports
Journal Article
Review
Langues
eng
Sous-ensembles de citation
IM
Pagination
44Références
Int J Dermatol. 2018 Apr;57(4):428-433
pubmed: 29377090
J Rheumatol. 2015 Mar;42(3):521-6
pubmed: 25320218
Pediatrics. 2017 Jan;139(1):
pubmed: 27999114
Hip Int. 2011 Jul-Aug;21(4):487-9
pubmed: 21936072
J Womens Health (Larchmt). 2004 Oct;13(8):939-53
pubmed: 15671709
J Am Acad Dermatol. 2013 Nov;69(5):808-809
pubmed: 24124810
JAMA Dermatol. 2018 Jul 1;154(7):847-849
pubmed: 29710282
Clin Rheumatol. 2007 Mar;26(3):460-2
pubmed: 17119860
Br J Dermatol. 2019 Feb;180(2):272-281
pubmed: 30216406
Pediatr Dermatol. 2003 Sep-Oct;20(5):421-6
pubmed: 14521561
Br J Dermatol. 2006 Feb;154(2):267-76
pubmed: 16433796
Arch Dermatol. 2011 Jun;147(6):681-6
pubmed: 21339420
J Am Acad Dermatol. 2014 Feb;70(2):387-8
pubmed: 24438961
Pediatrics. 2015 Aug;136(2):e333-43
pubmed: 26195533
Lancet. 2007 Mar 3;369(9563):767-778
pubmed: 17336654
Am J Hum Genet. 2005 May;76(5):794-803
pubmed: 15756637
Hum Mol Genet. 1996 Oct;5(10):1649-55
pubmed: 8894702
Br J Dermatol. 2019 Mar;180(3):484-495
pubmed: 29897631
Dermatoendocrinol. 2011 Apr;3(2):107-12
pubmed: 21695020
Cell Tissue Res. 2013 Feb;351(2):281-8
pubmed: 22864982
Br J Dermatol. 1996 Jun;134(6):1023-9
pubmed: 8763418
Dermatol Ther. 2013 Jan-Feb;26(1):1-15
pubmed: 23384016
J Dermatol Sci. 2006 May;42(2):83-9
pubmed: 16481150
Ann Rheum Dis. 2009 Jul;68(7):1159-64
pubmed: 18957482
Arthritis Rheumatol. 2019 Jun;71(6):1000-1010
pubmed: 30592383